Members of the vascular endothelial growth factor (VEGF) family have been identified as key molecules in the development of many of the adverse effects of retinopathy of prematurity (ROP), diabetic retinopathy (DR), age-related macular degeneration (AMD), and other ischemic and inflammatory retinopathies. The gene discussed is VEGFA; the disease is retinopathy of prematurity.